compounded semaglutide fda for weight loss | Blog FDA Warns About Compounded Versions

In a significant turn of events, however, Novo Nordisk and Hims & Hers announced on March 9, 2026, that they had resolved their dispute and entered into a new partnership

We utilize a range of advanced, evidence-based treatments to create your personalized weight loss plan

Studies on metabolic rate after GLP-1 medication discontinuation show that resting metabolic rate returns to predicted levels based on new body weight within 3-6 months

You may need to adjust medication doses or have carbohydrates available during longer workouts

At Via Nova Health, we provide personalized care and monitoring to ensure that GLP-1 injections are used safely and effectively as part of a comprehensive weight management strategy